There are no items in your cart
Add More
Add More
| Item Details | Price | ||
|---|---|---|---|
Language: English
Published by: Focus Medica India Pvt Ltd.,
Validity Period: 365 days
The Animated Atlas of Diabetes is a comprehensive collection of 63 animated videos pertaining to glucose metabolism, action of insulin in glucose uptake, diabetes, biological factors playing a role in the onset of diabetes, its complications and management.
| Anatomy of pancreas | |||
| Beta cell function | |||
| Glucose transport proteins (2:00) | |||
| Diabetes | |||
| Insulin | |||
| Insulin gene expression (2:00) | |||
| Mature beta granule storage pool (2:00) | |||
| Movement of secretory granules to the plasma membrane and exocytosis (2:00) | |||
| Role of C-peptide in the synthesis of insulin (2:00) | |||
| Insulin receptor structure and function (2:00) | |||
| Regulation of insulin receptor expression | |||
| Insulin like growth factors (3:00) | |||
| Insulin signalling pathways (3:00) | |||
| Regulation of proinsulin conversion (3:00) | |||
| Proteolytic enzymes involved in proinsulin conversion (2:00) | |||
| Inefficient conversion of proinsulin to insulin | |||
| Dysfunctional proinsulin processing in diabetes (2:00) | |||
| Insulin-mediated regulation of glucose metabolism (2:00) | |||
| Role of beta cell in glucose homeostasis (2:00) | |||
| Role of hypothalamus in peripheral glucose metabolism (2:00) | |||
| Incretins | |||
| GLP-1 receptor (2:00) | |||
| Leptin (2:00) | |||
| Gastrin releasing polypeptide (2:00) | |||
| NEFA (nonesterified fatty acids ) signalling (2:00) | |||
| Role of NEFAs in insulin resistance (2:00) | |||
| Genetic factors (melanocortin-4 receptor, leptin receptor, prohormone convertase 1) (3:00) | |||
| Polymorphisms of the insulin gene | |||
| Antibodies directed against islet cells (2:00) | |||
| Immunity directed against beta cells | |||
| IA-2 (ICA512) and IA-2β (phogrin)-membrane-associated autoantigen (2:00) | |||
| Anti-insulin antibody-mediated insulin resistance | |||
| CRABP-1 (cellular retinoic acid binding protein-1) and insulin resistance (2:00) | |||
| Role of IL-6 (interleukin-6) and insulin resistance | |||
| Tumour Necrosis Factor-α and insulin resistance (2:00) | |||
| Insulin resistance and type 2 diabetes (2:00) | |||
| C-peptide and Type 2 diabete | |||
| The functional basis for HLA class II association with type I diabetes (2:00) | |||
| Pathophysiology of maturity onset diabetes of the young type 2 (MODY 2) (3:00) | |||
| Diabetes secondary to pancreatitis | |||
| Obesity and insulin resistance (2:00) | |||
| Mitochondrial diabetes (2:00) | |||
| Gestational diabetes mellitus (2:00) | |||
| Diabetic foot (2:00) | |||
| Gangrene and diabetes (2:00) | |||
| Retinopathy (2:00) | |||
| Diabetic nephropathy | |||
| Diabetic ketoacidosis | |||
| Mechanism of metformin for the anithyperglycemic effect (2:00) | |||
| Site of primary action of oral sulfonylureas | |||
| Alpha-glucosidase inhibitors in the treatment of hyperglycemia (2:00) | |||
| Use of thiazolidinediones to decrease peripheral insulin resistance (2:00) | |||
| Use of meglitinides in the treatment of type 2 diabetes (2:00) | |||
| Different types of Insulin for treating diabetes (2:00) | |||
| Insulin pump therapy (2:00) | |||
| Role of DPP-4 (dipeptidyl peptidase-4) inhibitors in the treatment of diabetes orincretin-enhancing DPP4-inhibitors (2:00) | |||
| Synthetic recombinant exendin-4 (exenatide) (2:00) | |||
| Islet amyloid polypeptide (IAPP) therapy (2:00) | |||
| Role of PPAR-γ ligands (TZDS) in treating type 2 diabetes (2:00) | |||
| Gastric surgery in type 2 diabetes | |||
| New drugs for the treatment of diabetes mellitus (3:00) | |||
| Diabetes treatment targeting brain (resveratrol-sirtuins in brain) (2:00) | |||
Launch your Graphy
